Informations sur le nombre total de droits de vote et d'actions
Mont–Saint–Guibert (Belgique), le 23 mai 2025, 22:30h CET / 16:30h ET – [...] Read more »
Information on the total number of voting rights and shares
Information on the total number of voting rights and shares
Mont–Saint–Guibert (Belgium), May 23, 2025, 10:30 pm CET / 4:30 pm ET – In [...] Read more »
Swvl تطلق وحدة أعمال السفر الفاخر، ما يشرّع لها آفاق النمو بهوامش عالية في أسواقها التشغيلية ويتيح لها تحقيق أولى إيراداتها في دولة الإمارات
تقدم وحدة " Swvlللسفر [...] Read more »
Swvl Launches Luxury Travel Vertical, Unlocking High-Margin Growth Potential Across Its Operating Markets and Secures First Revenue in the UAE
Swvl Luxury Travel offers premium airport transfers, on–demand rides, intercity travel, meet–and–greet services, and event transportation
Launched and collaborating with [...] Read more »
Swvl Grows 12.4% Quarter on Quarter in IFRS Revenue, 47% Quarter on Quarter Growth in Revenue in Constant Currency, and Achieves $0.8 Million in Net Profit in Q1 2025
Revenue growth of 12.4%, and 47% in constant currency for Q1 2025 over Q1 2024
Achieved $0.8 million in Net Profit in Q1 2025
Dollar pegged revenue increased [...] Read more »
Nyxoah Présente ses Résultats Financiers et Opérationnels du Premier Trimestre
INFORMATIONS RÉGLEMENTÉES
Nyxoah Présente ses Résultats Financiers et Opérationnels du Premier Trimestre
La [...] Read more »
Nyxoah Reports First Quarter Financial and Operating Results
REGULATED INFORMATION
Nyxoah Reports First Quarter Financial and Operating Results
Company On Track for Anticipated PMA Approval in the Second Quarter of 2025 [...] Read more »
Publication relating to transparency notifications
Publication relative à des notifications de transparence
INFORMATION RÉGLEMENTÉE
Publication relative à des notifications de transparence
Read more »
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for [...] Read more »